Hedera Dx

Epalinges, Switzerland · Founded 2021 · Privately Held (backing)

Operator of a global cancer real-world data platform designed to enable molecular testing and AI-driven insights for improved cancer care outside the US. Hedera Dx is based in Epalinges, Switzerland and was founded in 2021. Its last reported valuation was $43 million in Mar 2024. It has raised $36.8 million.

Last reported valuation
$43.0M
Oct 2026
Priced at
—
Total raised
$36.8M
Last round
—

Who backs Hedera Dx?

11 investors
InvestorType
TA VenturesVenture capital
TesiOther
VSquared VenturesVenture capital
GRIDS CapitalOther
Blu Stone ManagementFamily office
Air Street Capital—
Amino Collective—
Helsana HealthInvest—
Inventure—
ReykVC—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hedera Dx investors

11 investors are on record for Hedera Dx, including TA Ventures, Tesi, VSquared Ventures and GRIDS Capital.

Free account
More of Hedera Dx with a free account
  • ·The complete investor list: 11 names
  • ·Watch Hedera Dx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Hedera Dx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View